Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Mar. 28, 2020
Mar. 30, 2019
Mar. 28, 2020
Mar. 30, 2019
Net sales $ 96,660 $ 102,838 $ 192,550 $ 204,513
Cost of goods sold 76,079 83,930 152,075 167,036
Gross profit 20,581 18,908 40,475 37,477
Selling, general and administrative expenses 17,941 17,056 36,147 33,841
Other (income) loss, net (914) (843) (1,863) 902
Operating income 3,554 2,695 6,191 2,734
Interest expense, net 1,808 1,985 3,610 3,750
Earnings (loss) before provision for (benefit from) income taxes 1,746 710 2,581 (1,016)
Provision for (benefit from) income taxes 526 (115) 570 (614)
Consolidated net earnings (loss) 1,220 825 2,011 (402)
Net loss attributable to non-controlling interest 91 117 223 193
Net earnings (loss) attributable to shareholders $ 1,311 $ 942 $ 2,234 $ (209)
Basic earnings (loss) per share (in dollars per share) $ 0.19 $ 0.14 $ 0.32 $ (0.03)
Diluted earnings (loss) per share (in dollars per share) $ 0.19 $ 0.13 $ 0.32 $ (0.03)
Weighted average number of shares outstanding (in shares) 6,957 6,943 6,953 6,933
Dilutive effect of stock awards (in shares) 98 160 110
Weighted average number of shares assuming dilution (in shares) 7,055 7,103 7,063 6,933